BOSTON SCIENTIFIC CORPORATION (NYSE:BSX) Files An 8-K Other Events

BOSTON SCIENTIFIC CORPORATION (NYSE:BSX) Files An 8-K Other Events
ITEM 8.01. Other Events.

Story continues below

On December27, 2018, Boston Scientific Corporation (the “Company”) announced the exercise of its option to acquire Millipede,Inc. Millipede,Inc. is a privately-held company that has developed the IRIS Transcatheter Annuloplasty Ring System for the treatment of severe mitral regurgitation.

A copy of the Company’s press release announcing the option exercise is included as Exhibit99.1 to this Current Report on Form8-K and incorporated herein by reference; provided, however, that information on or connected to the Company’s website or the website of any third-party hyperlinked from or referenced in the Company’s press release included as Exhibit99.1 to this Current Report on Form8-K is expressly not incorporated by reference into or intended to be filed as part of this Current Report on Form8-K.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d)Exhibits

BOSTON SCIENTIFIC CORP Exhibit
EX-99.1 2 a18-42121_1ex99d1.htm EX-99.1 Exhibit 99.1     Boston Scientific Exercises Option to Acquire Millipede,…
To view the full exhibit click here

About BOSTON SCIENTIFIC CORPORATION (NYSE:BSX)

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven core businesses: Interventional Cardiology, Peripheral Interventions (PI), Cardiac Rhythm Management (CRM), Electrophysiology (EP), Endoscopy, Urology and Pelvic Health, and Neuromodulation. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and PI businesses. Its Rhythm Management segment consists of CRM and EP businesses. Its MedSurg segment consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its interventional cardiology products include Drug-Eluting Coronary Stent Systems, Core Coronary Technology, Intravascular Imaging and Structural Heart Therapy. Its peripheral products include stents, balloon catheters, wires, peripheral embolization devices and vena cava filters.

An ad to help with our costs